Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring orthopedic ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...

Highlights of the findings include: Stopping Ozempic three to five days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia. In contrast ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Results presented here showed patients who had significant weight loss prior to total hip arthroplasty with use of a GLP-1 receptor agonist experienced a decreased risk for complications but an ...

This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 ...

GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these ...

Patients taking GLP-1 drugs also had a 31% lower risk of dying within five ... She is an associate professor of surgery and ...

“To minimize risks of delayed emergence from anesthesia, aspiration, aspiration pneumonitis, and conversion to intubation, ceasing GLP-1 RA 14 days before surgery is optimal,” the authors write.